ArticleEmerging infectious diseases2006
VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France.
Article in Emerging infectious diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Genomic insights into efflux-mediated biofilm persistence and multidrug resistance in Achromobacter xylosoxidans from cystic fibrosis.Archives of microbiology · 2026Article
- Where Do Milk Microbes Originate? Traceability of Microbial Community Structure in Raw Milk.Foods (Basel, Switzerland) · 2025Article
- Genetic and Biochemical Characterization of AXC-2 fromPathogens (Basel, Switzerland) · 2024Article
- An 18-Year Dataset on the Clinical Incidence and MICs to Antibiotics ofAntibiotics (Basel, Switzerland) · 2022Article
- Genomic characterization ofMicrobial genomics · 2021Article
- Review
- Review
- AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand.FEMS microbiology letters · 2020Article
- First Documented Case of Percutaneous Endoscopic Gastrostomy (PEG) Tube-Associated Bacterial Peritonitis due toCase reports in gastrointestinal medicine · 2020Article
- Role of AxyZ Transcriptional Regulator in Overproduction of AxyXY-OprZ Multidrug Efflux System in Achromobacter Species Mutants Selected by Tobramycin.Antimicrobial agents and chemotherapy · 2017Article
- Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.Frontiers in cellular and infection microbiology · 2017Article
- Bacterial Communities Associated with Atherosclerotic Plaques from Russian Individuals with Atherosclerosis.PloS one · 2016Article
- Hospital Acquired Pneumonia Due to Achromobacter spp. in a Geriatric Ward in China: Clinical Characteristic, Genome Variability, Biofilm Production, Antibiotic Resistance and Integron in Isolated Strains.Frontiers in microbiology · 2016Article
- Isolation of multiple drug-resistant enteric bacteria from feces of wild Western Lowland Gorilla (Gorilla gorilla gorilla) in Gabon.The Journal of veterinary medical science · 2015Article
- Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.Antimicrobial agents and chemotherapy · 2015Article
- Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains.Frontiers in microbiology · 2014Article
- Article
- First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.Antimicrobial agents and chemotherapy · 2011Article
- A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure.Antimicrobial agents and chemotherapy · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.